12:02 EST Brookfield still pursuing Grifols (GRFS) deal, Bloomberg reports
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GRFS:
- Grifols SA (GRFS) Q3 Earnings Cheat Sheet
- Grifols price target lowered to EUR 15.50 from EUR 15.60 at Berenberg
- Grifols receives FDA approval to treat surgical bleeding with FS solution
- Grifols partners with BARDA for PoC testing of ocular immunoglobulin
- Grifols subsidiary GigaGen awarded U.S. BARDA contract